Indeed, sub-clonal diversity is generated through both SHM and CSR, resulting in CLL sub-clones comprising of B-cells exhibiting BCR variants of the dominant CLL BCR. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.